MASIMO CORP — Director's Dealing 2023

Aug 12, 2023

SEC Form 4/A — Form 4/A

Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2023-08-11

Reporting Person: MASIMO CORP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-11	Common Stock	C	531548	—	Acquired	531548	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-11	Series A Preferred Stock	$	C	265774	Disposed		Common Stock (531548.0)	Direct
2023-08-11	Pre-Funded Warrant, Series A Preferred Stock (Right to Buy)	$0.0001	C	144890	Disposed		Series A Preferred Stock (144890.0)	Direct
2023-08-11	Pre-Funded Warrant, Common Stock (Right to Buy)	$0.0005	C	289779	Acquired		Common Stock (289779.0)	Direct

Footnotes

F1: Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.

F2: The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.